Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, et al. Preliminary safety and efficacy of first-line pertuzumab combined with
trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic
breast cancer (PERUSE). Ann Oncol 2019;30:766-773.
PMID: 31987343